Optimizing Study Start-up Through People and Technology
Our people, coupled with our technology – AcceleTrial®, utilize objective and subjective data, along with our proprietary algorithms, to access, extract, normalize, index, and integrate the information that you need. Our vast network of 300,000+ global investigators and clinical research sites uniquely empowers us to create a customizable site identification plan for your unique protocol and program. The result – the identification and access to the qualified sites, and best sites for your study, while realizing optimal sponsor and site satisfaction, due to the highly efficient and effective processes that we utilize.
LINEA System – helping you to achieve world-class study start-up results while saving time and money
How We Help Sponsors
Identification
Use evidence-based data to target sites with the right patients for your trial
Feasibility Questionnaire
Access responses in real-time for quick insight on your site’s capability to conduct the trial
Site Visit
Schedule dates for Pre-Study Site Visit and Site Initiation Visit to qualify sites, and provide training
Clinical Trial Agreement
Expedite contracts and initiate sites to accelerate patient enrollment
Regulatory / IRB
View regulatory essential documents and manage IRB/Ethics approvals
Drug Shipment
Monitor drug request and shipment
Enrollment
Track screening and enrollment to confirm activation
How We Help Sites
CDA
Expedite the Confidential Disclosure Agreement with auto-fills and digital signature
Feasibility Questionnaire
Immediate access to questionnaires to provide insights on site capability
Qualification
Provide required documents and coordinate sponsor visits
Clinical Trial Agreement
Facilitate negotiations on contracts with accuracy and clear communication
Regulatory / IRB
Upload essential regulatory documents and track IRB/Ethics submission and approvals
Enrollment
Report and track screening and enrollment to confirm activation
What Our Clients Are Saying
Who We Serve
We are proud to be recognized by MD Tech Review for our advancements in the clinical space!
To learn more about our first-of-its-kind Study Start-Up System (SSUS) and read the Q&A with our Founder and President, please click here.